United States · Who invested in Akero Therapeutics?
Akero Therapeutics's investors include Versant Ventures, Apple Tree Partners, venBio Partners, Atlas and General Atlantic, and 10 more on record.
201920202021202220232024
$65MSeries A$70MSeries B$367MRound
United States · Funded startup
Who invested in Akero Therapeutics
Funding summaryUpdated 26 Oct 2026
$502Mraised across 3 rounds since 2018, from 3 sources
$65MSeries A$70MSeries B$367MRound
- Latest round
- Round, $367MMar 2024
- Step-upi
- 5.2×
- Investors
- 15
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $65M Jun 2018
- Biggest round
- $367M Round · Mar 2024
- Usual gap between rounds
- 5.3 years the median of 2
The rounds
- Mar 2024Round$367M5 new
General Atlantic
Perceptive Advisors
Janus Henderson Investors
Cormorant Asset Management- Adage Capital Management
Source recorded
- Dec 2018Series B$70M6 new4 returning
Versant Ventures
Apple Tree Partners
venBio Partners
Cormorant Capital
Boxer Capital
Atlas- BVF Partners
LifeSci Venture Partners- Janus Henderson Investors/ Redmile Group
- Rock Springs
Reported by FinSMEsSEC filing: $45M sold, first sale Dec 2018
- Jun 2018
Founders and team
From Akero Therapeutics's own website and the SEC filings it signed: 9 on the team.
- Libette LuceVice President, Regulatory Affairs
- Sean DoyleVice President, Operations
- Yasmine RafidiVice President, Head of Finance
- Scott GangloffChief Technical Officer
- Jane Pritchett HendersonIndependent Board Member
- Tom HeymanIndependent Board Member
- Andrew ChengExecutive Officer, Directori
- Jonathan YoungExecutive Officeri
- Mark IwickiChairman
On the board, as filediAaron KantoffAaron RoystonGraham WalmsleyKevin Bitterman
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Adage Capital ManagementAsset manager1round
BVF PartnersVC firm1round
Janus Henderson Investors/ Redmile Groupno record of our own yet1round
Rock Springsno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Akero Therapeutics
How much has Akero Therapeutics raised?
Akero Therapeutics has raised $502M across 3 rounds since 2018.
When did Akero Therapeutics last raise?
Akero Therapeutics's most recent round was an Undisclosed round of $367M in Mar 2024.
What was Akero Therapeutics's biggest round?
Its most recent round, $367M in Mar 2024, is also its largest on record.
Who backed Akero Therapeutics first?
Akero Therapeutics's first round on record, in Jun 2018, was backed by Versant Ventures, Apple Tree Partners and venBio Partners and 1 others.
What stage is Akero Therapeutics at?
Akero Therapeutics's latest named round is an Undisclosed round, in Mar 2024.
Where is Akero Therapeutics based?
Akero Therapeutics is based in the United States.
Companies like Akero Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.